ArticleRespirology case reports2026
Use of Extracorporeal Membrane Oxygenation for Lung Cancer-Related Massive Hemoptysis: A Case Report and Literature Review.
Article in Respirology case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Use of Extracorporeal Membrane Oxygenation for Lung Cancer-Related Massive Hemoptysis: A Case Report and Literature Review.Respirology case reports · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Massive hemoptysis is a common, life-threatening complication of lung cancer, and asphyxiation due to major airway obstruction is the leading cause of death. Extracorporeal membrane oxygenation (ECMO) can temporarily replace pulmonary gas exchange, stabilize acute respiratory failure, and provide a window for definitive therapy. This case report describes a patient with squamous cell carcinoma who developed catastrophic hemoptysis and successfully underwent right pneumonectomy under venovenous ECMO support, followed by uneventful recovery and discharge. In addition, a focused literature review was conducted to examine the role and optimal timing of ECMO as an adjunct to surgery for lung cancer-related massive hemoptysis, offering practical insights for clinicians managing this critical condition.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.